Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL201307 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
mitogen-activated protein kinase 8/c-Jun N-terminal kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2276] [GtoPdb: 1496] [UniProtKB: P45983] | ||||||||
ChEMBL | Inhibitory activity against JNK1alpha | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL301] [GtoPdb: 1973] [UniProtKB: P24941] | ||||||||
ChEMBL | Inhibitory activity against CDK2 | B | 4.21 | pIC50 | 62000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibitory activity against EGFR | B | 6.1 | pIC50 | 800 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
ChEMBL | Inhibition of EGFR kinase | B | 6.1 | pIC50 | 800 | nM | IC50 | Nat Chem Biol (2006) 2: 358-364 [PMID:16783341] |
protein tyrosine kinase 2/Focal adhesion kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2695] [GtoPdb: 2180] [UniProtKB: Q05397] | ||||||||
ChEMBL | Inhibitory activity against FAK | B | 5.4 | pIC50 | 4000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibitory activity against human hERG receptor | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
Insulin-like growth factor I receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1957] [GtoPdb: 1801] [UniProtKB: P08069] | ||||||||
ChEMBL | Inhibitory activity against IGFR | B | 4.89 | pIC50 | 13000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
mitogen-activated protein kinase 14/MAP kinase p38 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL260] [GtoPdb: 1499] [UniProtKB: Q16539] | ||||||||
ChEMBL | Inhibitory activity against p38-alpha MAPK | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
aurora kinase A/Serine/threonine-protein kinase Aurora-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4722] [GtoPdb: 1936] [UniProtKB: O14965] | ||||||||
GtoPdb | - | - | 9 | pIC50 | <1 | nM | IC50 | J Med Chem (2006) 49: 955-70 [PMID:16451062] |
ChEMBL | Inhibition of Aurora A kinase activity | B | 9 | pIC50 | <1 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
ChEMBL | Inhibition of aurora A kinase | B | 9 | pIC50 | <1 | nM | IC50 | J Med Chem (2009) 52: 2629-2651 [PMID:19320489] |
ChEMBL | Inhibition of Aurora A kinase | B | 9 | pIC50 | <1 | nM | IC50 | Nat Chem Biol (2006) 2: 358-364 [PMID:16783341] |
aurora kinase B/Serine/threonine-protein kinase Aurora-B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2185] [GtoPdb: 1937] [UniProtKB: Q96GD4] | ||||||||
GtoPdb | - | - | 8.15 | pIC50 | <7 | nM | IC50 | J Med Chem (2006) 49: 955-70 [PMID:16451062] |
ChEMBL | Inhibition of aurora B kinase | B | 8.15 | pIC50 | 7 | nM | IC50 | J Med Chem (2009) 52: 2629-2651 [PMID:19320489] |
ChEMBL | Inhibition of Aurora B kinase | B | 8.15 | pIC50 | 7 | nM | IC50 | Nat Chem Biol (2006) 2: 358-364 [PMID:16783341] |
C-terminal Src kinase/Tyrosine-protein kinase CSK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2634] [GtoPdb: 1994] [UniProtKB: P41240] | ||||||||
ChEMBL | Inhibitory activity against CSK | B | 4.68 | pIC50 | 21000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
Janus kinase 3/Tyrosine-protein kinase JAK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2148] [GtoPdb: 2049] [UniProtKB: P52333] | ||||||||
ChEMBL | Inhibitory activity against JAK3 | B | 4.6 | pIC50 | 25000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibitory activity against SRC | B | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibitory activity against KDR | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (2006) 49: 955-970 [PMID:16451062] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]